The startup develops biological-protein-based adhesives and biomimetic surface technologies that utilize nanocomposite coatings to eliminate a wide range of bacteria and viruses on various materials, including medical devices and textiles. These coatings provide a safer and more effective alternative to traditional silane-based grafting methods, particularly in moist environments.
Funding
$670K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Hospital-acquired infections (HAIs) from contaminated surfaces and medical devices contribute to millions of deaths globally each year. Current methods for preventing microbial adhesion and biofilm formation on medical devices and other surfaces are often ineffective, especially in moist environments, and can pose toxicity risks. This is particularly problematic for indwelling devices like catheters, which are major contributors to hospital-acquired sepsis cases.
Solution
ACatechol develops biomimetic surface technologies that utilize nanocomposite coatings to prevent microbial adhesion and kill pathogens on contact. Their patented Gemini surface technology provides durable, long-lasting germicidal efficacy, addressing the issue of surface transmission of infectious diseases. These coatings offer a safer and more effective alternative to traditional methods, particularly in moist environments. ACatechol's technology is designed to prevent biofilm formation on medical devices, such as catheters, and enhance the wet-adhesion of medical devices to biological tissues.
Target Audience
The primary target audience includes medical device manufacturers, hospitals, and healthcare providers seeking to reduce hospital-acquired infections and improve patient outcomes, as well as strategic partners and investors for its antimicrobial & anti-biofouling surface technology.
Features
- Biomimetic coatings inspired by mussel foot proteins
- Gemini surface technology for durable residual germicidal efficacy
- Prevents adhesion of microorganisms
- Kills pathogens on contact
- Non-toxic and biodegradable materials
- Anti-biofilm and anti-infective properties for catheters
- Wet-bonding technology for strong surgical adhesives